You searched for "hearing"

3630 results found

In conversation with Shelly Chadha 2019

Shelly Chadha works at the World Health Organisation as the Medical Officer for ear and hearing care. Here, Alex Griffiths-Brown interviews her to find out more about her career, challenges she’s faced and her ambitions for the future. Shelly Chadha....

The AuD at Salus University: a Capstone Experience

Here, we continue exploring audiology training routes across the world with a focus on distance learning opportunities. This article is provided by Karen Myers who completed the Doctor of Audiology (AuD) Online Bridge programme at Salus University. Completing the International...

ENT in this issue...Multidisciplinary Teams

Joanne Rimmer, MBBS, MA(Hons) Cantab, FRCS(ORL-HNS), FRACS, Consultant Otolaryngologist / Rhinologist, Monash Health; Honorary Senior Lecturer, Department of Surgery, Monash University, Melbourne, Australia. E: rimmer.joanne@gmail.com The multidisciplinary team (MDT) has long been regarded as the gold standard in cancer care,...

Immunosuppresants and ototoxicity

There is a wide range of immunosuppressant drugs ranging from calcineurin inhibitors (e.g. cyclosporine), anti-folic agents (e.g. methotrexate) to anti-TNF and monoclonal antibodies, many of which could be ototoxic. The authors performed a systematic review assessing ototoxicity secondary to immunosuppressant...

Ear wax: the good, the bad, and the ugly

With ear wax removal being a core part of ENT and audiology services, Seth Schwartz gives us his dos and don’ts. We have all seen cartoons where a character pulls enough wax out of their ears to make a candle....

Kuduwave™ testing aboard the ISS

What does it take to make an audiometer and tympanometry ready for the space age? In a recent interview, Jillian Scotland and Dirk Koekemoer shared their first-hand experience of getting the Kuduwave ready for a voyage to the ISS. It...

Follow-up of NF2 patients with ABRs, SDS and MRI

Hearing loss is one of the earliest manifestations in vestibular schwannomas with 60% of the patients having high frequency loss. Several metabolic and mechanical factors influencing the cochlea and cochlear nerve have been implicated in the hearing decline noted in...

Cochlear implants in single sided deafness

Whilst the benefit of a second cochlear implant in people with bilateral deafness is well established, the benefits of implantation for single sided deafness with normal contralateral hearing have been much more modest. The reasons for this are varied, in...

Transcutaneous vs. percutaneous bone conduction devices

Bone conduction devices (BCD) have proven to be effective options for hearing amplification in patients who are not candidates for conventional hearing aids. This study prospectively surveyed 70 patients with BCD using the COSI (Client Oriented Scale of Improvement) and...

‘Bare below the elbows’

So it has finally happened. I have reached that stage of reactionary bewilderment known as middle age. As well having my finger nowhere near the pulse of contemporary culture, I am finding the siren charms of BBC Radio 2 and...

Early results of the Cochlear Osia (active transcutaneous bone-conduction implant) in teenagers

This funded research trial involving 14 adolescents, aged 10 to 17 years, in the Toronto Hospital for Sick Kids was carried out just prior to the new Osia implant obtaining FDA approval for use in the USA. The majority had...

Cochlear implants and therapeutics: a natural partnership?

Global awareness of cochlear implants as a solution for hearing loss is slowly increasing and gaining acceptance. The potential for combining cochlear implants with inner ear therapeutics is immense, with promise in several areas. This article takes us on a...